In this issue:
Use of CAM in IBDs
London Position Statement on biological therapy
Second-line rescue therapy in ulcerative colitis
Increased mesalazine dose beneficial in UC?
Risk of hypovitaminosis D in young IBD patients
Shortened infliximab infusion times in IBD
5-aminosalicylate: not chemoprophylactic for CRC in IBD
Small bowel adenocarcinoma and CT enterography
Dietary intake and IBD symptoms
Transitional care in IBD
Science Blog: The role of PTPN2 in auto-inflammatory disease pathogenesis
Please login below to download this issue (PDF)